SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-139482
Filing Date
2023-05-09
Accepted
2023-05-09 16:43:05
Documents
16
Period of Report
2023-05-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d611852d8k.htm   iXBRL 8-K 29258
2 EX-1.1 d611852dex11.htm EX-1.1 198742
3 EX-5.1 d611852dex51.htm EX-5.1 12866
7 GRAPHIC g611852dsp48.jpg GRAPHIC 4260
8 GRAPHIC g611852dsp49.jpg GRAPHIC 3186
  Complete submission text file 0001193125-23-139482.txt   432110

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fdmt-20230504.xsd EX-101.SCH 2899
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fdmt-20230504_lab.xml EX-101.LAB 17979
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fdmt-20230504_pre.xml EX-101.PRE 11291
10 EXTRACTED XBRL INSTANCE DOCUMENT d611852d8k_htm.xml XML 3360
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39782 | Film No.: 23902872
SIC: 2836 Biological Products, (No Diagnostic Substances)